BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6166759)

  • 1. Specific red cell adherence: immunologic evaluation of random mucosal biopsies in carcinoma of the bladder.
    Stein BS; Reyes JM; Petersen RO; McNellis D; Kendall AR
    J Urol; 1981 Jul; 126(1):37-40. PubMed ID: 6166759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specific red cell adherence test in transitional cell carcinoma of the bladder before and after radiotherapy in patients with blood group A.
    Wolk FN; Bishop MC
    J Urol; 1983 Jul; 130(1):71-3. PubMed ID: 6345808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course.
    Limas C; Lange P; Fraley EE; Vessella RL
    Cancer; 1979 Dec; 44(6):2099-107. PubMed ID: 509389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific red cell adherence testing and radiotherapy.
    Stein BS; Kendall AR
    Cancer; 1982 Dec; 50(11):2329-32. PubMed ID: 7139529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ABO (H) antigen negative transitional cell tumours with abnormal mucosal biopsies in superficial bladder cancer.
    Das G
    Arch Ital Urol Nefrol Androl; 1988 Sep; 60(3):295-9. PubMed ID: 2975863
    [No Abstract]   [Full Text] [Related]  

  • 11. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder.
    Selli C; Cozzolino F; Vercelli D; Mincione GP
    Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group antigens and bladder carcinoma: a perspective.
    Stein BS; Kendall AR
    Urology; 1982 Sep; 20(3):229-33. PubMed ID: 7123712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder.
    Lange PH; Limas C; Fraley EE
    J Urol; 1978 Jan; 119(1):52-5. PubMed ID: 621815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific red cell adherence test and unspecific immune response in patients with superficial bladder cancer.
    Jakse G; Hofstädter F; Märk R
    Urol Int; 1981; 36(3):171-7. PubMed ID: 7025414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific red cell adherence test applied to tumors of ureter and renal pelvis.
    Gruber MB; Becker SN; Warren MM; Rambo MJ; Davis CP
    Urology; 1982 Apr; 19(4):361-5. PubMed ID: 7072026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder tumors: when to do and what to expect from random mucosal biopsies with reference to blood group cell surface antigens.
    Boccon-Gibod L; Boccon-Gibod L; Desligneres S; Janin-Mercier A
    Eur Urol; 1987; 13(1-2):1-6. PubMed ID: 3582436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Leu-M1 antigens in carcinoma of the urinary bladder.
    Hoshi S; Orikasa S; Numata I; Nose M
    J Urol; 1986 May; 135(5):1075-7. PubMed ID: 3083124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherence.
    Flanigan RC; King CT; Clark TD; Cash JB; Greenfield BJ; Sniecinski IJ; Primus FJ
    J Urol; 1983 Sep; 130(3):499-503. PubMed ID: 6350617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.